While this article has focused on the differing requirements for people using GLP-1s for weight loss, the list of proposed indications for GLP-1s grows seemingly on a daily basis, with research currently ongoing in neurodegenerative disease, chronic kidney disease and liver disease
Simultaneously, these agents suppress glucagon secretion from pancreatic alpha cells, further helping to regulate blood glucose levels
Fortunately, these are typically mild, temporary, and occur mostly during dose adjustments
Analysis shows approximately 80% of verified customer reviews on Amazon and Trustpilot are 1-2 stars, with users citing no hunger suppression and skin irritation
Some describe a subjective change in how alcohol makes them feel, with diminished pleasure or increased nausea when drinking
doi: 10.1016/j.ijpharm.2023.123718